DK0945465T3 - Antagonistiske monoklonale antistoffer mod humant CD40 - Google Patents

Antagonistiske monoklonale antistoffer mod humant CD40

Info

Publication number
DK0945465T3
DK0945465T3 DK99104709T DK99104709T DK0945465T3 DK 0945465 T3 DK0945465 T3 DK 0945465T3 DK 99104709 T DK99104709 T DK 99104709T DK 99104709 T DK99104709 T DK 99104709T DK 0945465 T3 DK0945465 T3 DK 0945465T3
Authority
DK
Denmark
Prior art keywords
antibodies
antibody
cells
treat
insect cells
Prior art date
Application number
DK99104709T
Other languages
English (en)
Inventor
Boer Mark De
Leah B Conroy
Original Assignee
Novartis Vaccines & Diagnostic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27360277&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0945465(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/910,222 external-priority patent/US5397703A/en
Application filed by Novartis Vaccines & Diagnostic filed Critical Novartis Vaccines & Diagnostic
Application granted granted Critical
Publication of DK0945465T3 publication Critical patent/DK0945465T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2827—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against B7 molecules, e.g. CD80, CD86
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK99104709T 1992-07-09 1993-07-08 Antagonistiske monoklonale antistoffer mod humant CD40 DK0945465T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US07/910,222 US5397703A (en) 1992-07-09 1992-07-09 Method for generation of antibodies to cell surface molecules
US08/015,147 US5869050A (en) 1992-07-09 1993-02-09 Methods of blocking T-cell activation using anti-B7 monoclonal antibodies
US08/070,158 US5677165A (en) 1992-07-09 1993-05-28 Anti-CD40 monoclonal antibodies capable of blocking B-cell activation
PCT/US1993/006432 WO1994001547A2 (en) 1992-07-09 1993-07-08 A method for generation of antibodies to cell surface molecules

Publications (1)

Publication Number Publication Date
DK0945465T3 true DK0945465T3 (da) 2007-01-15

Family

ID=27360277

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99104709T DK0945465T3 (da) 1992-07-09 1993-07-08 Antagonistiske monoklonale antistoffer mod humant CD40

Country Status (5)

Country Link
EP (3) EP0651797B1 (da)
AT (2) ATE258595T1 (da)
DE (2) DE69334064T2 (da)
DK (1) DK0945465T3 (da)
ES (1) ES2273452T3 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5397703A (en) 1992-07-09 1995-03-14 Cetus Oncology Corporation Method for generation of antibodies to cell surface molecules
WO2001034649A2 (en) * 1999-11-09 2001-05-17 Chiron Corporation Compositions and methods for treating autoimmune diseases and transplant rejections
CN1450912A (zh) * 2000-04-19 2003-10-22 泰诺士公司 用于治疗牛皮癣和其它炎性皮肤病的cd40拮抗剂
US7063845B2 (en) 2000-04-28 2006-06-20 Gemini Science, Inc. Human anti-CD40 antibodies
AU2001259215A1 (en) * 2000-04-28 2001-11-12 La Jolla Institute For Allergy And Immunology Human anti-cd40 antibodies and methods of making and using same
WO2002028905A2 (en) * 2000-10-02 2002-04-11 Chiron Corporation Human anti-cd40 antibodies
EP2009027B1 (en) 2001-04-27 2014-05-21 Kyowa Hakko Kirin Co., Ltd. Anti-CD40 monoclonal antibody
DE10132308A1 (de) * 2001-07-06 2003-01-30 Aventis Behring Gmbh Kombinationspräparat zur Therapie von immunologischen Erkrankungen
WO2003028809A1 (en) * 2001-10-02 2003-04-10 Chiron Corporation Methods of therapy for b-cell malignancies
WO2003029296A1 (en) * 2001-10-02 2003-04-10 Chiron Corporation Human anti-cd40 antibodies
JP2008509080A (ja) * 2004-04-27 2008-03-27 ノバルティス ヴァクシンズ アンド ダイアグノスティクス， インコーポレイテッド アンタゴニスト抗ｃｄ４０モノクローナル抗体およびその使用方法
EP1854810A1 (en) 2006-05-09 2007-11-14 PanGenetics B.V. Deimmunized antagonistic anti-human CD40 monoclonal antibody from the ch5D12 antibody
WO2017059243A2 (en) * 2015-09-30 2017-04-06 Janssen Biotech, Inc. Agonistic antibodies specifically binding human cd40 and methods of use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992000092A1 (en) * 1990-07-02 1992-01-09 Bristol-Myers Squibb Company Ligand for cd28 receptor on b cells and methods

Also Published As

Publication number Publication date
ATE258595T1 (de) 2004-02-15
EP0651797A1 (en) 1995-05-10
ES2273452T3 (es) 2007-05-01
EP0945465B1 (en) 2006-09-13
DE69334064D1 (de) 2006-10-26
ATE339451T1 (de) 2006-10-15
EP0651797B1 (en) 2004-01-28
DE69333403D1 (de) 2004-03-04
DE69334064T2 (de) 2007-05-24
EP0945465A1 (en) 1999-09-29
EP1834671A3 (en) 2013-05-22
DE69333403T2 (de) 2004-11-11
EP1834671A2 (en) 2007-09-19

Similar Documents

Publication Publication Date Title
WO1994001547A3 (en) A method for generation of antibodies to cell surface molecules
DK0945465T3 (da) Antagonistiske monoklonale antistoffer mod humant CD40
Warner et al. Bone marrow graft rejection as a function of antibody-directed natural killer cells.
MX9201016A (es) Anticuerpos monoclonales humanizados y quimericos
DE69128253T2 (de) Bispezifische antikörper, verfahren zu ihrer herstellung und deren verwendungen
DE69636748D1 (de) Bispezifischer antikörper zur effektiven behandlung von b-zell lymphomen und zellinien
EP0722463A4 (en) METHOD AND COMPOSITION FOR MODULATING THE ECONOMIC RESPONSE RESPONSE TO ALLERGENS
NL990008I2 (nl) CD#2#5 bindende molekulen.
DE59209079D1 (de) Monoklonale Antikörper gegen humane Pankreas-Inselzellen
JPH10505325A (ja) 治療剤としてのｔ細胞に対する抗体
Murphy et al. CD40 stimulation promotes human secondary immunoglobulin responses in HuPBL-SCID chimeras
WO1995034581A1 (en) Inhibition of human xenogenic or allogenic antibodies to reduce xenograft or allograft rejection in human recipients
DE3851492D1 (de) Ein gattungsspezifisches Listeria-Antigen, identifiziert durch monoklonale Antikörper.
PL314414A1 (en) Antiidiotypic antibodies capable to induce an immunological response in respect to the receptor of epidermis growth factor
Dennert et al. Induction of bone marrow allograft rejection and hybrid resistance in nonresponder recipients by antibody: is there evidence for a dual receptor interaction in acute marrow graft rejection?
FI20095269A (fi) Lymfosyyttien sitoutumiseen vaikuttava ihmisen endoteelisolun molekyyli
Kremmer et al. Induction and suppression of anti-antibodies to syngeneic T cell-binding antibodies in mice
Thierfelder et al. Immunosuppression by Fc region‐mismatched anti‐T cell antibody treatment
EP0380018A3 (en) Rat monoclonal antibodies directed against human antigens and processes for preparation thereof
Else et al. Antibody isotype responses to Trichuris infection in humanized SCID mice
Mysliwietz et al. Long‐lasting unresponsiveness to polyclonal T cell‐binding immunoglobulins
STRoNG et al. Anti-idiotype antibody in the primate
Mateo et al. A different method for obtaining an engineered murine antibody, that recognizes epidermal growth factor receptor, with reduced immunogenicity
De Boer et al. Method for generation of antibodies to cell surface molecules
TH13147EX (th) อนุพันธ์ของฮีสตามีนและวิธีการใช้มันเพื่อเป็นตัวเปลี่ยนแปลงแบบอิมมูน